NeuroClues vs RetinAI (2026): Pricing, Features & Which to Choose

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

Lower starting price
Not comparable
Not comparable: NeuroClues does not list a price
Free plan
Tie
Neither has one
Higher rating
NeuroClues
4.3 against 4.1
Same job?
Yes
Both are Healthcare AI tools

Side by side

Compared on	NeuroClues	RetinAI
Our rating	4.3Better	4.1
Starts at	Not listed	Not listed
Free plan	No	No
Category	Healthcare AI	Healthcare AI
Plans	See pricing	See pricing
Key features	Portable, CE-marked Class IIa medical device for clinical eye-movement recording Calibration-free patient setup using dual infrared cameras at 400 fps AI-derived biomarkers benchmarked against reference ranges for clinical interpretation Early-detection targeting for Parkinson's, Alzheimer's, and multiple sclerosis Deployment across university hospitals and private neurology practices in seven-plus countries	OCT Atlas CE-marked for AMD, DR, DME and glaucoma LuxIA CE-MDR certified for diabetic retinopathy screening Discovery UNITY for unified imaging data Editions for multi-centre clinical studies and for clinics Automatic segmentation across device formats
Pros	CE-marked Class IIa medical device status gives it real regulatory clearance, not only research-stage promise More than €22 million raised, including a €10 million Series A, signals investor confidence Aims at detection years before visible symptoms, where neurological treatment has the most impact	CE marking separates it from research-only imaging tools Handles data from multiple scanner formats Serves clinics, trials and pharma from one platform
Cons	No published pricing, and as a clinical device it is sold directly to institutions, not individuals Limited so far to the European market and CE marking, without confirmed FDA clearance As a diagnostic aid, findings still require a neurologist's clinical interpretation, not a standalone verdict	No published pricing CE marking is not FDA clearance; availability differs by market Supports the ophthalmologist's decision rather than replacing it
Company	neuroClues, founded 2020	Ikerian AG

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is NeuroClues better than RetinAI?

In our reviews NeuroClues scores 4.3 and RetinAI scores 4.1. The better pick depends on the job. NeuroClues: Eye-tracking medical device that uses AI to detect early biomarkers of Parkinson's, Alzheimer's, and multiple sclerosis. RetinAI: CE-marked retinal imaging analysis for clinics, trials and pharmaceutical research.

Which is cheaper, NeuroClues or RetinAI?

NeuroClues: see pricing. RetinAI: see pricing.

Do NeuroClues and RetinAI have free plans?

Neither lists a free plan.

More comparisons

NeuroClues compared with

All NeuroClues alternatives

RetinAI compared with

All RetinAI alternatives